Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Schrödinger abandons CDC7 inhibitor linked to 2 patient deaths
Schrödinger is abandoning its CDC7 inhibitor after the therapy was linked to the deaths of two patients in a phase 1 leukemia trial.
James Waldron
Aug 14, 2025 8:23am
Generative AI models build new antibiotics from scratch
Aug 14, 2025 11:00am
Lilly pens $1.3B pact with Superluminal to work on GPCR drugs
Aug 14, 2025 9:45am
Prelude calls it curtains on lead SMARCA2 cancer asset
Aug 14, 2025 10:44am
CytomX reports patient death from kidney injury in ADC trial
Aug 14, 2025 6:45am
Evotec's reorg claims 600 jobs, 200 more than originally planned
Aug 14, 2025 2:44pm
More News
New Vicarious CEO pushes back surgical robot timeline
Aug 14, 2025 1:30pm
Apple Watch gets blood oxygen tracking back with software update
Aug 14, 2025 11:30am
Sarepta sells 9M Arrowhead shares for $174M cash
Aug 13, 2025 5:44pm
Fierce Biotech Layoff Tracker 2025: Vedanta, Abata & more
Aug 13, 2025 4:30pm